AMP Horizons Optical Genome Mapping: About its Potential in Routine Human Genetic Diagnostics


 Optical Genome Mapping: About its Potential in Routine Human Genetic Diagnostic

This contains the webinar recording
Continuing education credit is no longer available for this webinar


Description:

Optical genome mapping (OGM) is an upcoming diagnostic method that allows the discovery of structural variants difficult to detect by other means. With a workload acceptable for a routine laboratory, OGM is able to acquire high-resolution breakpoints of balanced and unbalanced structural variants. However, as any other novel technique, its associated capabilities and limitations are unfamiliar to the majority of the scientific community, which deters potential users.

Learn here about the capabilities of OGM. Find out if it is a useful complement to the diagnostic objectives of your facility.


Learning Objectives:

  • Recognize the capabilities and limitations of optical genome mapping
  • Evaluate fields of molecular and cytogenetic diagnostics that could profit from optical genome mapping
  • Develop diagnostic pipelines where optical genome mapping contributes to improved patient care




Speaker:
Paul Dremsek, MD
Center for Pathbiochemistry and Genetics
Medical University of Vienna

Moderator:

Shashi Shetty, PhD
Case Western Reserve University
University Hospitals Cleveland Medical Center


Duration: 1 Hour
Level of Instruction: Intermediate
Date Recorded: September 15, 2022

Planned and coordinated by the Training and Education Committee

Continuing Education Credit Information

Continuing education credit is no longer available for this webinar. 


Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.